Encore Pharmaceuticals Inc., a California-based biotechnology company, has received a $750,000 Phase 2 Small Business Innovation Research (SBIR) award from the National Institute on Aging. The grant award will support continued collaborative research and development in the field of neuroinflammation between EncorePharma researchers and Drs. Kenneth Hensley and Robert Floyd, scientists at the Oklahoma Medical […]
News
ONEOK donates $50,000 to the Oklahoma Medical Research Foundation
ONEOK, Inc., has awarded $50,000 grant to the Oklahoma Medical Research Foundation, the two organizations announced today. The gift from the Tulsa-based energy company will be used to fund research on Alzheimer’s disease. “We are very pleased to partner with ONEOK in the battle against a terrible disease that affects more than 4 million older […]
How I spent my summer vacation-part two
When summer comes, many teachers seek out a poolside lounge, a good paperback or one of many other relaxing diversions to help them recover from the grueling school year. But for one Newkirk educator, the end of the school year signals the beginning of her second job: serving as guidance counselor, den mother and drill […]
How I spent my summer vacation…
The public school teacher stereotype carries many myths. Teachers work short hours. They have lots of holidays. They spend three months sitting by the pool or vacationing every summer. But for teachers like Marlow High’s Bill Ray, summer’s no break. It’s back to work, learning more about science and, now, teaching other educators to do […]
Charity Navigator gives top ranking to OMRF
The Oklahoma Medical Research Foundation has once again earned four stars from Charity Navigator, America’s largest charity evaluator. This is the fourth consecutive year in which OMRF has received the prestigious four-star rating, Charity Navigator’s top possible score. “In earning our highest four-star rating, the Oklahoma Medical Research Foundation has demonstrated exceptional financial health, outperforming […]
OMRF scientist identifies potential key player in cancer
An Oklahoma Medical Research Foundation scientist has identified novel functions for an enzyme that may play an important role in causing cancers to become malignant and resistant to drug treatment. The discovery could have clinical relevance for the treatment of cancer. OMRF scientist Gary J. Gorbsky, Ph.D., has detailed his research in the journal Current […]
